Acumen Pharmaceuticals Files Prospectus To Resell Up To 10,833,331 Shares From March 16, 2026 Private Placement

Acumen Pharmaceuticals has filed a prospectus to allow the resale of up to 10,833,331 shares of its common stock, which were issued in a private placement on March 16, 2026. The selling stockholders may sell these shares at various prices on any stock exchange or through private transactions. Acumen will not receive any proceeds from these sales, and the company's common stock is listed on the Nasdaq under the ticker 'ABOS,' with a last reported sale price of $2.63 per share on March 25, 2026.